研究成果 (25)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/1

A D E F H I L P S T 全部

TIGER 1: A Randomized, Open-Label, Phase 2/3 Study of Rociletinib (CO-1686) or Erlotinib as First-Line Treatment for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
CAMIDGE D Ross, WOLF Juergen, LITTEN Jason B, HIGASHI Linda A, ISAACSON Jeffrey D, MOK Shu Kam Tony ( 2015 )
Invited conference paper presented and published in conference proceedings
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres (SIRT-Y90) followed by Gemcitabine plus Cisplatin for Intra-Hepatic Cholangiocarcinoma: A Phase II Study
CHOO Su Pin, TAI David W M, NG David, LI Leung, YU Ch Simon, CHAN Lam Stephen ( 2015 )
Invited conference paper presented and published in conference proceedings
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Sarcomas
LOONG Herbert Ho Fung, CHOY C H, CHEONG Hio Teng, U K P, WONG Chi Hang ( 2015 )
Connective Tissue Oncology Society, Annual Meeting
Invited conference paper presented and published in conference proceedings
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Sarcomas
CHOY, Chi Tung, CHEONG, Hio Teng, U Kin Pong, WONG Chi Hang, LOONG Herbert Ho Fung ( 2015 )
AACR Annual Meeting 2015
Invited conference paper presented and published in conference proceedings
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Gliomas
LOONG Herbert Ho Fung, CHOY, Chi Tung, CHEONG, Hio Teng, LI Y, U Kin Pong, WONG Chi Hang ( 2015 )
EORTC-EANO-ESMO 2015, 27-28 March 2015, Istanbul, Turkey
Invited conference paper presented and published in conference proceedings
Preclinical Evaluation of Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Gliomas
LOONG Herbert Ho Fung, CHOY Chi Tung, CHEONG Hio Teng, LI Yi, CHAN Ka Yin Aden, U K P, WONG Chi Hang ( 2015 )
20th Annual Society for Neuro-Oncology Annual Scientific Meeting and Education Day
Invited conference paper presented and published in conference proceedings
Phase 3 KEYNOTE-042 Trial of Pembrolizumab (MK-3475) versus Platinum Doublet Chemotherapy in Treatment-Naive Patients (pts) with PD-L1-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
MOK Shu Kam Tony, WU Yi Long, WATSON Patricia A, ZHANG Jin, RANGWALA Reshma A, LOPES Gilberto ( 2015 )
2015 ASCO Annual Meeting
Invited conference paper presented and published in conference proceedings
Phase 1/2 Safety and Antitumor Activity of Nivolumab in Patients with Advanced Hepatocellular Carcinoma (HCC): CA209-040
EI-KHOUEIRY A, MELERO I, CROCENZI T, WELLING T, YAU T, YEO Winnie, CHOPRA A, GROSSO J, LANG L, ANDERSON J, CRUZ C, SANGRO B ( 2015 )
51st Annual Meeting of American Society Of Clinical Oncology
Invited conference paper presented and published in conference proceedings
Low awareness of breast cancer, common subtypes and treatment options among Hong Kong women
TSANG J, YUNG S T, NG K, NGAN K C, LEUNG C W, KWOK C C, SUEN J J, NG T Y, SOONG I S, YEO Winnie ( 2015 )
14th St.Gallen International Breast Cancer Conference
Invited conference paper presented and published in conference proceedings
Lipid profiles of young Chinese breast cancer after adjuvant chemotherapy
YEO Winnie, YIP C H, MO Kwok Fai, PANG Elizabeth Summing, YIP C C, LEE K M, CHAN V, SUEN J, HO W M, LIEM T G ( 2015 )
IMPAKT Breast Cancer Conference
Invited conference paper presented and published in conference proceedings
Integration of Albumin-Bilirubin (ALBI) Score into Current Tumour Staging System for Hepatocellular Carcinoma (HCC)
CHAN Lam Stephen, TO Ka Fai, MO Kwok Fai, CHONG Ching Ning Charing, YEO Winnie, JOHNSON J. Philip, LAI Bo San Paul, CHAN Wing Hung Anthony ( 2015 )
Invited conference paper presented and published in conference proceedings
Impact of Crizotinib on Patient-Reported General Health Status Compared with Chemotherapy in Patients with No Prior Systemic Treatment for Advanced Non-Squamous ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
FELIP Enriqueta, BLACKHALL Fiona Helen, MOK Shu Kam Tony, CAPPUZZO Federico, WILNER Keith D, REISMAN Arlene, IYER Shrividya, SOLOMON Benjamin J ( 2015 )
Invited conference paper presented and published in conference proceedings
Historical milestones of treatment advancement in metastatic gastric cance (abstract book SS_4)
YEO Winnie ( 2015 )
Invited conference paper presented and published in conference proceedings
Final Overall Survival (OS) Results of the Phase III PROCLAIM Trial: Pemetrexed (Pem), Cisplatin (Cis) or Etoposide (Eto), Cis plus Thoracic Radiation Therapy (TRT) followed by Consolidation Cytotoxic Chemotherapy (CTX) in Locally Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
SENAN Suresh, BRADE Anthony M, WANG Luhua, VANSTEENKISTE Johan F, DAKHIL Shaker R, BIESMA Bonne, AGUILLO Maite Martinez, AERTS Joachim, GOVINDAN Ramaswamy, RUBIO VIQUEIRA Belen, LEWANSKI Conrad R, GANDARA David R, CHOY Hak, MOK Shu Kam Tony, HOSSAIN Anwar, ISCOE Neill Allan, TREAT Joseph, KOUSTENIS Andrew G, CHOUAKI Nadia, VOKES Everett E ( 2015 )
Invited conference paper presented and published in conference proceedings
ESTABLISHING THE ROLE OF ARGININE DEPRIVATION WITH THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN THE TREATMENT OF ADULT GLIOMAS
Herbert Loong, CT Choy, HT Cheong, Y Li ( 2015 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/neuonc/nov204.51
Enhancing doctor-patient communication: The key to optimal treatment (program book)
YEO Winnie ( 2015 )
Invited conference paper presented and published in conference proceedings
EGFR Mutant Subset Analysis from Archer 1009: A Randomized Double Blind Phase 3 Efficacy and Safety Study of Dacomitinib versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
PAZ-ARES L, O BYRNE K, MOK Shu Kam Tony, BOYER M, JANNE P A, GOLDBERG Z, MATHER C, TAYLOR I, ZHANG H, RAMALINGAM S S ( 2015 )
Invited conference paper presented and published in conference proceedings
Early menopause and comorbidities among Chinese breast cancer women after adjuvant chemotherapy
LIEM G S, PANG Elizabeth Summing, SUEN J, MO Kwok Fai, YIP H W, LEE K M, HO W M, CHAN T C, KOH Chun, YEO Winnie ( 2015 )
14 th St. Gallen International Breast Cancer Conference, Primary Therapy of Early Breast Cancer
Invited conference paper presented and published in conference proceedings
Developing a CAncer Genomics Digital Educational Tool to Assess the Knowledge and Expectations of Patients with Advanced Solid Tumors (CADET)
LOONG Herbert Ho Fung, SPREAFICO Anna, COOK Natalie, CHAN Kelvin K, KRISHNA Geeta D, CHOW Helen, YU Celeste, KANG Steve, BLANCHETTE Phillip Stanley, BEDARD Philippe L, RAZAK Albiruni R A, SIU Lillian L ( 2015 )
2015 ASCO Annual Meeting
Invited conference paper presented and published in conference proceedings
AURA3 Design: A Randomised, Phase III Study of AZD9291 versus Second-Line Chemotherapy for Patients (PTS) with EGFR-TKI-Resistant (T790M) Advanced Non-Small Cell Lung Cancer
WU Y L, PAPADIMITRAKOPOULOU V A, GHIORGHIU S, TEMPLETON A, MOK Shu Kam Tony ( 2015 )
Invited conference paper presented and published in conference proceedings
ASCEND-3: A Single-Arm, Open-Label, Multicenter Phase II Study of Ceritinib in ALKi-naive Adult Patients (pts) with ALK-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC)
FELIP Enriqueta, ORLOV Sergey, PARK Keunchil, YU Chong Jen, TSAI Chun Ming, NISHIO Makoto, DOLS Manuel Cobo, MCKEAGE Mark James, SU Wu Chou, MOK Shu Kam Tony, SCAGLIOTTI Giorgio V, SPIGEL David, BRANLE Fabrice, EMEREMNI Chetachi, QUADRIGLI Massimiliano, SHAW Alice Tsang ( 2015 )
Invited conference paper presented and published in conference proceedings
ASCEND-2: A Single-Arm, Open-Label, Multicenter Phase II Study of Ceritinib in Adult Patients (pts) with ALK-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Chemotherapy and Crizotinib (CRZ)
MOK Shu Kam Tony, SPIGEL David, FELIP Enriqueta, DEMARINIS Filippo, AHN Myung Ju, GROEN Harry J M, WAKELEE Heather A, HIDA Toyoaki, CRINO Lucio, NISHIO Makoto, SCAGLIOTTI Giorgio V, BRANLE Fabrice, EMEREMNI Chetachi, QUADRIGLI Massimiliano, ZHANG Jie, SHAW Alice Tsang ( 2015 )
Invited conference paper presented and published in conference proceedings
A randomized Phase 3 Study Comparing First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance (PC/G) with Gefitinib Monotherapy (G) in East Asian Patients (pts) with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (nSqNSCLC): Final Survival Results
YANG James Chih Hsin, SRIMUNINNIMIT Vichien, AHN Myung Ju, LIN Chia Chi, KIM Sang We, TSAI Chun Ming, MOK Shu Kam Tony, ORLANDO Mauro, PURI Tarun, WANG Xin, PARK Keunchil ( 2015 )
Invited conference paper presented and published in conference proceedings
A Phase II Study of Oral ENMD-2076 in Advanced Soft Tissue Sarcoma (STS)
ZER Alona, LOONG Herbert Ho Fung, GUPTA Abha, HOGG David, BRADBURY Penelope, NYQUIST-SCHULTZ Kjirsten, BAKER Stephanie, WANG Lisa, RAZAK Albiruni R ( 2015 )
Connective Tissue Oncology Society, Annual Meeting
Invited conference paper presented and published in conference proceedings
A Multicenter Phase 1B Study of Ceritinib plus Nivolumab in Patients with ALK+NSCLC P1.01-085 (ID 1323)
SHAW A, LOONG Herbert Ho Fung, TAN D S, GRISCTI K, GAO H, FINCKENSTEIN F, SCOTT J, VANSTEENKISTE J ( 2015 )
16th World Conference on Lung Cancer
Invited conference paper presented and published in conference proceedings

10 | 25 | 50 | 100

1/1

研究成果 (25)

分享連結

Our policy towards the use of cookies